Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Piccini

Showing results (281-290 of 662) with videos related to

Pageof 67
Sort By:
The American Journal of Cardiology|September 29, 2023
Expert Consensus on Comprehensive Early Rhythm Control in Addition to Guideline-Based Care for Atrial Fibrillation: A Modified Delphi SurveyThomas F Deering, Jonathan P Piccini, Marlon Graf, et al.
Heart Rhythm|July 5, 2023
Left ventricular lead implantation failure in an unselected nationwide cohortDaniel J Friedman, Li Qin, James V Freeman, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 24, 2023
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) surveyJames A Reiffel, Carina Blomström-Lundqvist, Giuseppe Boriani, et al.
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
American Heart Journal|March 8, 2017
Cardioversion and subsequent quality of life and natural history of atrial fibrillationSean D Pokorney, Sunghee Kim, Laine Thomas, et al.
Journal of the American College of Cardiology|March 21, 2020
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal DiseaseSean D Pokorney, Eric Black-Maier, Anne S Hellkamp, et al.
Journal of the American Heart Association|May 6, 2016
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) RegistryEmily C O'Brien, Sunghee Kim, Laine Thomas, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 29, 2017
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationLuigi Di Biase, David Callans, Karl Georg Hæusler, et al.
Journal of the American Heart Association|January 19, 2022
Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT TrialBrian Mac Grory, Jonathan P Piccini, Shadi Yaghi, et al.
Journal of Cardiovascular Translational Research|May 28, 2020
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19Marat Fudim, Yawar J Qadri, Kamrouz Ghadimi, et al.
Pageof 67

Showing results (281-290 of 662) with videos related to

Sort By:
Pageof 67
The American Journal of Cardiology|September 29, 2023
Expert Consensus on Comprehensive Early Rhythm Control in Addition to Guideline-Based Care for Atrial Fibrillation: A Modified Delphi SurveyThomas F Deering, Jonathan P Piccini, Marlon Graf, et al.
Heart Rhythm|July 5, 2023
Left ventricular lead implantation failure in an unselected nationwide cohortDaniel J Friedman, Li Qin, James V Freeman, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 24, 2023
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) surveyJames A Reiffel, Carina Blomström-Lundqvist, Giuseppe Boriani, et al.
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
American Heart Journal|March 8, 2017
Cardioversion and subsequent quality of life and natural history of atrial fibrillationSean D Pokorney, Sunghee Kim, Laine Thomas, et al.
Journal of the American College of Cardiology|March 21, 2020
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal DiseaseSean D Pokorney, Eric Black-Maier, Anne S Hellkamp, et al.
Journal of the American Heart Association|May 6, 2016
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) RegistryEmily C O'Brien, Sunghee Kim, Laine Thomas, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 29, 2017
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationLuigi Di Biase, David Callans, Karl Georg Hæusler, et al.
Journal of the American Heart Association|January 19, 2022
Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT TrialBrian Mac Grory, Jonathan P Piccini, Shadi Yaghi, et al.
Journal of Cardiovascular Translational Research|May 28, 2020
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19Marat Fudim, Yawar J Qadri, Kamrouz Ghadimi, et al.
Pageof 67